David Abrams' Top Holdings Analysis: Strategic Investments in Alphabet Inc (GOOGL), Somnigroup International Inc (TPX), and Nuvation Bio Inc (NUVB)

As of March 31, 2026, David Abrams, managing the investment firm Abrams Capital Management, has positioned his portfolio with a strategic focus on large-cap technology and consumer cyclical stocks, alongside a small-cap healthcare holding. The total portfolio value stands at approximately $4.64 billion, with the top three holdings representing key sectors and demonstrating varying levels of investor engagement.

The largest position in Abrams' portfolio is held by Alphabet Inc (GOOGL), commonly known as Google. This investment, representing 11.57% of the total portfolio value, consists of 1,865,768 shares valued at $536.5 million. Compared to the previous period, Abrams reduced his stake in Alphabet by 50,862 shares, indicating a slight divestment, with the share count decreasing by 2.65%.

Second on the list is Somnigroup International Inc (TPX), a consumer cyclical company. Abrams holds 5,798,776 shares of TPX, accounting for 9.24% of the portfolio and valued at $428.6 million. The position shows minimal change, with only 5,360 fewer shares held, representing a negligible 0.09% decrease in share count from the prior period.

Rounding out the top three holdings is Nuvation Bio Inc (NUVB), a healthcare-focused biotechnology company. The investment amounts to just $5.45 million, or 0.12% of the portfolio, held in 1,270,504 shares. This position has seen a dramatic reduction, with Abrams selling off 2,541,009 shares, resulting in a 66.67% decrease in the share count since the last reporting period.

For more detailed information on David Abrams' investment activities, you can visit his profile on InsiderSet: Abrams Capital Management Investor Profile. To explore the companies in his portfolio, click on the respective stock symbols: GOOGL, TPX, and NUVB.